Refresh

GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

500660 GLAXO Group (A) BSE data
Back to Company

Results

Statement

More

Cash Flow
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Profit before tax

952.65 837.49 2,470.04 722.33 646.99

Net cashflow-operating activity

578.94 487.94 819.79 594.87 490.97

Net cash used in investing activity

14.97 805.19 -419.66 407.57 -63.10

Netcash used in fin. activity

-561.50 -1,544.18 -524.24 -695.56 -427.62

Net inc/dec in cash and equivlnt

32.41 -251.05 -124.11 306.87 0.25

Cash and equivalnt begin of year

29.74 280.79 404.90 98.03 97.78

Cash and equivalnt end of year

62.15 29.74 280.79 404.90 98.03
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com